Literature DB >> 15801018

Increased incidence of carcinoma of the tongue in patients with systemic sclerosis.

Chris T Derk1, Mehmoodur Rasheed, Joseph R Spiegel, Sergio A Jimenez.   

Abstract

OBJECTIVE: To describe the incidence of carcinoma of the tongue in a large cohort of patients with systemic sclerosis (SSc).
METHODS: In total, 769 patients with SSc were prospectively followed over 16 years for the development of cancer. Patients with a diagnosis of carcinoma of the tongue were identified to determine the incidence of this cancer in SSc. The results were compared to the incidence of tongue cancer in the SEER cancer registries.
RESULTS: A total of 3775 patient-years of followup of 769 patients with SSc (392 diffuse cutaneous, 377 limited cutaneous) prospectively evaluated for the occurrence of cancer disclosed 9 patients who were diagnosed with oral cavity and pharyngeal carcinomas. Six of these patients had squamous cell carcinoma of the tongue. One of these had both pharyngeal and tongue squamous cell carcinomas within a 4-year period, and another had 3 separate squamous cell carcinomas of the tongue. The standardized incidence ratio of squamous cell carcinoma of the tongue observed in this cohort of patients with SSc was 25-fold higher than that expected in an age adjusted population from the SEER cancer registries. All patients with SSc identified within this cohort with oral cavity carcinomas had the diffuse subset of the disease.
CONCLUSION: There is a highly significant increase in the incidence of squamous cell carcinoma of the tongue in patients with SSc. A remarkable observation was that all patients within this cohort who developed oral cancer had the diffuse subset of SSc. This suggests a relationship between the etiology or pathogenesis of the diffuse form of SSc and development of squamous cell carcinoma of the tongue in this group of patients.

Entities:  

Mesh:

Year:  2005        PMID: 15801018      PMCID: PMC6744938     

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

1.  Areca nut use: an independent risk factor for oral cancer.

Authors:  Saman Warnakulasuriya; Chetan Trivedy; Timothy J Peters
Journal:  BMJ       Date:  2002-04-06

Review 2.  Systemic sclerosis: environmental and occupational risk factors.

Authors:  P J Nietert; R M Silver
Journal:  Curr Opin Rheumatol       Date:  2000-11       Impact factor: 5.006

Review 3.  Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.

Authors:  Sergio A Jimenez; Chris T Derk
Journal:  Ann Intern Med       Date:  2004-01-06       Impact factor: 25.391

Review 4.  Aristolochic acid nephropathy: what we know and what we have to do.

Authors:  Xiaomei Li; Haiyan Wang
Journal:  Nephrology (Carlton)       Date:  2004-06       Impact factor: 2.506

5.  Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications.

Authors:  C H Chang; Y M Wang; A H Yang; S S Chiang
Journal:  Am J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.754

6.  Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry.

Authors:  E Ward; P Boffetta; A Andersen; D Colin; P Comba; J A Deddens; M De Santis; G Engholm; L Hagmar; S Langard; I Lundberg; D McElvenny; R Pirastu; D Sali; L Simonato
Journal:  Epidemiology       Date:  2001-11       Impact factor: 4.822

7.  Risk of cancer in patients with scleroderma: a population based cohort study.

Authors:  C L Hill; A-M Nguyen; D Roder; P Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

8.  A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].

Authors:  S A Jimenez; S H Sigal
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

Review 9.  Understanding the biology of oral cancer.

Authors:  Bibhu R Das; Jatin K Nagpal
Journal:  Med Sci Monit       Date:  2002-11

10.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

View more
  13 in total

Review 1.  Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 2.  Management of Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy in a Patient with Scleroderma: Case Report and Review of the Literature.

Authors:  David P Horowitz; Balazs Halmos; John Poneros; Joshua Sonett; Helen Remotti; Ryan J Burri
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 3.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

Review 4.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

Review 5.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

6.  Mechanistic and clinical insights at the scleroderma-cancer interface.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  J Scleroderma Relat Disord       Date:  2017-10-05

Review 7.  Orofacial consequences of systemic sclerosis: A systematic review.

Authors:  Rawen Smirani; Nicolas Poursac; Adrien Naveau; Thierry Schaeverbeke; Raphaël Devillard; Marie-Elise Truchetet
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 8.  Systemic Sclerosis Association with Malignancy.

Authors:  Gemma Lepri; Martina Catalano; Silvia Bellando-Randone; Serena Pillozzi; Elisa Giommoni; Roberta Giorgione; Cristina Botteri; Marco Matucci-Cerinic; Lorenzo Antonuzzo; Serena Guiducci
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

9.  Orofacial manifestations of systemic sclerosis.

Authors:  B J Veale; R Y Jablonski; T M Frech; J D Pauling
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

Review 10.  Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review.

Authors:  Korbinian Benz; Christine Baulig; Stephanie Knippschild; Frank Peter Strietzel; Nicolas Hunzelmann; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.